Understanding the role of DDX41 in blood disorders
The functional role of DDX41 in myelodysplastic syndromes
['FUNDING_FELLOWSHIP'] · NORTHWESTERN UNIVERSITY AT CHICAGO · NIH-10975035
This study is looking at how changes in the DDX41 gene can cause blood problems in people with myelodysplastic syndromes (MDS), which might lead to leukemia, and it aims to find new treatments for patients dealing with these issues.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NORTHWESTERN UNIVERSITY AT CHICAGO (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-10975035 on ClinicalTrials.gov |
What this research studies
This research investigates how mutations in the DDX41 gene contribute to myelodysplastic syndromes (MDS), which can lead to acute myeloid leukemia (AML). The study aims to uncover the molecular and cellular mechanisms by which DDX41 mutations cause blood cell abnormalities and apoptosis. By using models such as zebrafish and mice, researchers will explore the effects of DDX41 loss on hematopoietic cells and identify which blood cell lineages are most affected. The ultimate goal is to develop targeted therapies for patients with DDX41-related MDS.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with myelodysplastic syndromes or those with known DDX41 mutations.
Not a fit: Patients without myelodysplastic syndromes or those whose conditions are unrelated to DDX41 mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new targeted treatments for patients with myelodysplastic syndromes caused by DDX41 mutations.
How similar studies have performed: Previous studies have shown promising results in understanding the role of DDX41 mutations in blood disorders, indicating potential for success in this research.
Where this research is happening
CHICAGO, UNITED STATES
- NORTHWESTERN UNIVERSITY AT CHICAGO — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BI, HONGHAO — NORTHWESTERN UNIVERSITY AT CHICAGO
- Study coordinator: BI, HONGHAO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.